IDEANOMICS INC (IDEX)
US45166V2051 - Common Stock
We assign a fundamental rating of 1 out of 10 to IDEX. IDEX was compared to 132 industry peers in the Machinery industry. IDEX has a bad profitability rating. Also its financial health evaluation is rather negative. IDEX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IDEX had negative earnings in the past year.
In the past year IDEX has reported a negative cash flow from operations.
IDEX had negative earnings in each of the past 5 years.
In the past 5 years IDEX always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -224.62%, IDEX is doing worse than 97.67% of the companies in the same industry.
The Return On Equity of IDEX (-1393.74%) is worse than 94.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -224.62% | ||
| ROE | -1393.74% | ||
| ROIC | N/A |
ROA(3y)-67.81%
ROA(5y)-62.03%
ROE(3y)-102%
ROE(5y)-129.85%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IDEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
IDEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IDEX has more shares outstanding
The number of shares outstanding for IDEX has been increased compared to 5 years ago.
IDEX has a better debt/assets ratio than last year.
2.2 Solvency
IDEX has an Altman-Z score of -12.75. This is a bad value and indicates that IDEX is not financially healthy and even has some risk of bankruptcy.
IDEX's Altman-Z score of -12.75 is on the low side compared to the rest of the industry. IDEX is outperformed by 92.25% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that IDEX is not too dependend on debt financing.
IDEX has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: IDEX outperforms 43.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.75 |
ROIC/WACCN/A
WACC6.19%
2.3 Liquidity
IDEX has a Current Ratio of 0.42. This is a bad value and indicates that IDEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.42, IDEX is doing worse than 97.67% of the companies in the same industry.
A Quick Ratio of 0.27 indicates that IDEX may have some problems paying its short term obligations.
IDEX's Quick ratio of 0.27 is on the low side compared to the rest of the industry. IDEX is outperformed by 96.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.42 | ||
| Quick Ratio | 0.27 |
3. Growth
3.1 Past
IDEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.65%.
Looking at the last year, IDEX shows a very negative growth in Revenue. The Revenue has decreased by -49.01% in the last year.
IDEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.92% yearly.
EPS 1Y (TTM)-158.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q42.46%
Revenue 1Y (TTM)-49.01%
Revenue growth 3Y31.28%
Revenue growth 5Y-6.92%
Revenue growth Q2Q-97.26%
3.2 Future
The Earnings Per Share is expected to grow by 41.37% on average over the next years. This is a very strong growth
IDEX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 128.25% yearly.
EPS Next Y99.62%
EPS Next 2Y41.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year198.73%
Revenue Next 2Y128.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for IDEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IDEX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IDEX's earnings are expected to grow with 41.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.37%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for IDEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IDEANOMICS INC
NASDAQ:IDEX (4/25/2024, 7:00:01 PM)
After market: 0.87 -0.02 (-1.69%)0.885
+0.03 (+4%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.62M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -224.62% | ||
| ROE | -1393.74% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.42 | ||
| Quick Ratio | 0.27 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-158.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y99.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-49.01%
Revenue growth 3Y31.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y